Gene Information
Gene Name
|
MAP2K5 |
Gene ID
|
5607
|
Gene Full Name
|
mitogen-activated protein kinase kinase 5 |
Gene Alias
|
MEK5; MAPKK5; PRKMK5; HsT17454 |
Transcripts
|
ENSG00000137764
|
Virus
|
HBV |
Gene Type
|
protein coding |
HPA Location Info
|
Microtubules;Nucleoli;
|
HPA Protein Class Info
|
Enzymes, Predicted intracellular proteins |
Uniport_ID
|
Q13163
|
HGNC ID
|
HGNC:6845
|
VEGA ID
|
OTTHUMG00000133264
|
OMIM ID
|
602520 |
String ID
|
9606.ENSP00000178640
|
Drugbank ID
|
BE0009414
|
Drug (Cytoscape Annotation)
|
Vandetanib;Sorafenib Tosylate;Dasatinib;Nilotinib;ErlotinibHydrochloride;Bosutinib;Pazopanib Hydrochloride;Gefitinib;Sunitinib Malate;Axitinib |
PharmGKB ID
|
PA30590
|
Target gene [MAP2K5] related to VISs
DVID |
Chromosome |
HM |
TFBS |
CA |
Sum of Overlapped Records |
Detail |
1004819 |
chr15 |
13 |
52 |
3 |
68 |
View |
1015577 |
chr15 |
2 |
|
|
2 |
View |
Relationship between gene expression and immune infiltrating cell level
Data ID |
Disease |
Sample number |
Sample type |
GSE114783 (GEO) |
Chronic HBV (CHB) infection |
36 |
Chronic hepatitis B patients (HBV+)(10),Hepatocellular carcinoma (HBV+)(10),Liver cirrhosis(HBV+)(10),Normal(3),HBV carriers (3) |
GSE114783 (GEO) |
Hepatocellular carcinoma |
36 |
Chronic hepatitis B patients (HBV+)(10),Hepatocellular carcinoma (HBV+)(10),Liver cirrhosis(HBV+)(10),Normal(3),HBV carriers (3) |
GSE114783 (GEO) |
Liver cirrhosis |
36 |
Chronic hepatitis B patients (HBV+)(10),Hepatocellular carcinoma (HBV+)(10),Liver cirrhosis(HBV+)(10),Normal(3),HBV carriers (3) |
LIHC (TCGA) |
Liver hepatocellular carcinoma |
424 |
Liver hepatocellular carcinoma HCV (HBV+)(86), Liver hepatocellular carcinoma HCV (HBV-)(19), Liver hepatocellular carcinoma (HBV+)(209), Liver hepatocellular carcinoma (HBV+)(60), Paracancerous HCV (HBV+)(4), Paracancerous (HBV-)(28), Paracancerous (HBV+)(18) |
> Dataset: GSE114783
|
HeatMap of cell type fractions in all samples
|
Lollipop of MAP2K5 expression and immune infiltrating cell level correlation result in HBV+ Chronic HBV (CHB) infection samples
|
MAP2K5 expression: Low -> High
|
|
Lollipop of MAP2K5 expression and immune infiltrating cell level correlation result in HBV+ Liver cirrhosis samples
|
Lollipop of MAP2K5 expression and immune infiltrating cell level correlation result in HBV+ Hepatocellular carcinoma samples
|
|
|
|
> Dataset: LIHC
|
HeatMap of cell type fractions in all samples
|
Lollipop of MAP2K5 expression and immune infiltrating cell level correlation result in HBV+ samples
|
MAP2K5 expression: Low -> High
|
|
|
|
|